Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations.

Bukabau JB, Yayo E, Gnionsahé A, Monnet D, Pottel H, Cavalier E, Nkodila A, Makulo JRR, Mokoli VM, Lepira FB, Nseka NM, Krzesinski JM, Sumaili EK, Delanaye P.

Kidney Int. 2019 May;95(5):1181-1189. doi: 10.1016/j.kint.2018.11.045. Epub 2019 Mar 12.

PMID:
30910379
2.

Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis.

Delanaye P, Bataille S, Quinonez K, Buckinx F, Warling X, Krzesinski JM, Pottel H, Burtey S, Bruyère O, Cavalier E.

J Ren Nutr. 2019 Jan 25. pii: S1051-2276(18)30280-2. doi: 10.1053/j.jrn.2018.11.010. [Epub ahead of print]

PMID:
30686748
3.
4.

[How I explore… a proteinuria].

Résimont G, Gadisseur R, Lutteri L, Krzesinski JM, Cavalier E, Delanaye P.

Rev Med Liege. 2018 Oct;73(10):519-525. French.

5.

What we need to know about lipid-associated injury in case of renal ischemia-reperfusion.

Erpicum P, Rowart P, Defraigne JO, Krzesinski JM, Jouret F.

Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1714-F1719. doi: 10.1152/ajprenal.00322.2018. Epub 2018 Oct 17.

6.

[Screening and management of metabolic acidosis in patients with chronic kidney disease].

Georges B, Huart J, Krzesinski JM, Jouret F.

Rev Med Suisse. 2018 Aug 22;14(615):1455-1458. French.

PMID:
30136461
7.

Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literature.

Huart J, Krzesinski JM, Jouret F.

Clin Kidney J. 2018 Aug;11(4):586-596. doi: 10.1093/ckj/sfy020. Epub 2018 Apr 3.

8.

Hand grip strength measurement in haemodialysis patients: before or after the session?

Delanaye P, Quinonez K, Buckinx F, Krzesinski JM, Bruyère O.

Clin Kidney J. 2018 Aug;11(4):555-558. doi: 10.1093/ckj/sfx139. Epub 2017 Dec 19.

9.

Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients.

Paquot F, Delanaye P, Warling X, Moonen M, Smelten N, Jouret F, Krzesinski JM, Maillard N, Pottel H, Evenepoel P, Cavalier E.

Clin Chim Acta. 2018 Nov;486:183-184. doi: 10.1016/j.cca.2018.08.003. Epub 2018 Aug 4. No abstract available.

PMID:
30086264
10.

Is Very Low Always Useful? The Case of Very Low-Grade Albuminuria in Kidney Disease.

Cohen EP, Krzesinski JM.

Kidney Int Rep. 2018 Mar 11;3(4):769-770. doi: 10.1016/j.ekir.2018.03.003. eCollection 2018 Jul. No abstract available.

11.

[Hypertensive crisis].

Xhignesse P, Krzesinski F, Krzesinski JM.

Rev Med Liege. 2018 May;73(5-6):326-332. Review. French.

12.

[Bradykinin and cardiovascular protection. Role of perindopril, an inhibitor of angiotensin conversion enzyme].

Lancellotti P, Ancion A, D'Orio V, Gach O, Maréchal P, Krzesinski JM.

Rev Med Liege. 2018 Apr;73(4):197-205. Review. French.

13.

[Which place for thiazide and thiazide-like diuretics in patients with type 2 diabetes ?]

Scheen AJ, Krzesinski JM.

Rev Med Liege. 2018 Apr;73(4):176-182. Review. French.

14.

[Lower limb oedema in a patient with type 2 diabetes].

Scheen AJ, Paquot N, Lancellotti P, Krzesinski JM.

Rev Med Liege. 2018 Feb;73(2):101-106. French.

15.

Performance of glomerular filtration rate estimation equations in Congolese healthy adults: The inopportunity of the ethnic correction.

Bukabau JB, Sumaili EK, Cavalier E, Pottel H, Kifakiou B, Nkodila A, Makulo JRR, Mokoli VM, Zinga CV, Longo AL, Engole YM, Nlandu YM, Lepira FB, Nseka NM, Krzesinski JM, Delanaye P.

PLoS One. 2018 Mar 2;13(3):e0193384. doi: 10.1371/journal.pone.0193384. eCollection 2018.

16.

[Post-obstructive diuresis : diagnosis and management].

Piraprez M, Quinonez K, Sempels M, Waltrégny D, Krzesinski JM, Jouret F.

Rev Med Liege. 2017 Dec;72(12):529-533. French.

17.

[Type 1 primary hyperoxaluria: From childhood to adult, how to manage adequately medical therapy compliance?]

Leflot M, Krzesinski JM, Collard L, Thomas A, Ghuysen MS.

Nephrol Ther. 2018 May;14(3):148-152. doi: 10.1016/j.nephro.2017.06.004. Epub 2017 Dec 6. French.

18.

[Lupus nephropathy: Insight in new treatments].

Jadot V, Krzesinski JM, Von Frenckell C, Bovy C, Bouquegneau A.

Nephrol Ther. 2018 Feb;14(1):1-12. doi: 10.1016/j.nephro.2017.05.002. Epub 2017 Nov 27. Review. French.

19.

Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know.

Delanaye P, Paquot F, Bouquegneau A, Blocki F, Krzesinski JM, Evenepoel P, Pottel H, Cavalier E.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1404-1410. doi: 10.1093/ndt/gfx282.

PMID:
29048521
20.

Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.

Delanaye P, Warling X, Moonen M, Smelten N, Jouret F, Krzesinski JM, Maillard N, Pottel H, Cavalier E.

Sci Rep. 2017 Oct 3;7(1):12623. doi: 10.1038/s41598-017-12808-3.

21.

[Proton-pump inhibitors and risk of kidney disease].

Paquot F, Krzesinski JM.

Rev Med Suisse. 2017 Aug 23;13(571):1427-1430. French.

PMID:
28837280
22.

Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats.

Erpicum P, Rowart P, Poma L, Krzesinski JM, Detry O, Jouret F.

Sci Rep. 2017 Aug 17;7(1):8687. doi: 10.1038/s41598-017-08726-z.

23.

Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1.

Rowart P, Erpicum P, Krzesinski JM, Sebbagh M, Jouret F.

Stem Cells Int. 2017;2017:9717353. doi: 10.1155/2017/9717353. Epub 2017 Jul 11.

24.

Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods.

Hanssen O, Erpicum P, Lovinfosse P, Meunier P, Weekers L, Tshibanda L, Krzesinski JM, Hustinx R, Jouret F.

Clin Kidney J. 2017 Feb;10(1):97-105. doi: 10.1093/ckj/sfw062. Epub 2016 Jul 28. Review.

25.

Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples.

Erpicum P, Hanssen O, Weekers L, Lovinfosse P, Meunier P, Tshibanda L, Krzesinski JM, Hustinx R, Jouret F.

Clin Kidney J. 2017 Feb;10(1):106-115. doi: 10.1093/ckj/sfw077. Epub 2016 Sep 6. Review.

26.

Implications of the calcium-sensing receptor in ischemia/reperfusion.

Paquot F, Huart J, Defraigne JO, Krzesinski JM, Jouret F.

Acta Cardiol. 2017 Apr;72(2):125-131. doi: 10.1080/00015385.2017.1291136. Epub 2017 Feb 28.

PMID:
28597792
27.
28.

[Bipressil® : first single-pill combination of bisoprolol and perindopril arginine].

Gach O, Falque B, Canivet A, Krzesinski F, Krzesinski JM, Lancellotti P.

Rev Med Liege. 2017 May;72(5):260-265. Review. French.

29.

IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report.

Huart J, Grosch S, Bovy C, Moutschen M, Krzesinski JM.

BMC Nephrol. 2017 Apr 26;18(1):139. doi: 10.1186/s12882-017-0561-2.

30.

[Cardiovascular and renal protection of patients with type 2 diabetes : focus after EMPA-REG OUTCOME and LEADER].

Scheen AJ, Piérard L, Krzesinski JM, Paquot N.

Rev Med Liege. 2016 Sep;71(9):376-381. Review. French.

31.

Impact of the type of dialysis membranes on the circulating concentration of markers of vitamin D metabolism.

Cavalier E, Torres PU, Dubois BE, Smelten N, Pottel H, Krzesinski JM, Delanaye P.

Int J Artif Organs. 2017 Mar 16;40(2):43-47. doi: 10.5301/ijao.5000565. Epub 2017 Feb 18.

PMID:
28222207
32.

[Atrial fibrillation and anticoagulation in hemodialysis patients: A complex decision].

Delanaye P, Bouquegneau A, Dubois BE, Sprynger M, Mariat C, Krzesinski JM, Lancellotti P.

Nephrol Ther. 2017 Apr;13(2):59-66. doi: 10.1016/j.nephro.2016.09.002. Epub 2017 Feb 16. Review. French.

PMID:
28216253
33.

The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline.

Weekers L, Vanderweckene P, Pottel H, Castanares-Zapatero D, Bonvoisin C, Hamoir E, Maweja S, Krzesinski JM, Delanaye P, Jouret F.

Nephrol Dial Transplant. 2017 Jan 1;32(1):196-200. doi: 10.1093/ndt/gfw351.

PMID:
27798197
34.

Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion Injury.

Jouret F, Leenders J, Poma L, Defraigne JO, Krzesinski JM, de Tullio P.

PLoS One. 2016 Sep 22;11(9):e0163021. doi: 10.1371/journal.pone.0163021. eCollection 2016.

35.

Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease.

Neuville M, Hustinx R, Jacques J, Krzesinski JM, Jouret F.

PLoS One. 2016 Aug 16;11(8):e0161277. doi: 10.1371/journal.pone.0161277. eCollection 2016.

36.

The Case | Acute renal failure and refractory hyponatremia.

Denis C, Jadot V, Bouquegneau A, Krzesinski JM.

Kidney Int. 2016 Sep;90(3):713-4. doi: 10.1016/j.kint.2016.02.038. No abstract available.

PMID:
27521124
37.

The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function.

Jadoul A, Lovinfosse P, Weekers L, Delanaye P, Krzesinski JM, Hustinx R, Jouret F.

Clin Nucl Med. 2016 Sep;41(9):683-7. doi: 10.1097/RLU.0000000000001298.

PMID:
27405040
38.

[HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].

Schils R, Krzesinski JM.

Rev Med Liege. 2016 May;71(5):262-8. Review. French.

39.
40.

Creatinine-based equations for the adjustment of drug dosage in an obese population.

Bouquegneau A, Vidal-Petiot E, Moranne O, Mariat C, Boffa JJ, Vrtovsnik F, Scheen AJ, Krzesinski JM, Flamant M, Delanaye P.

Br J Clin Pharmacol. 2016 Feb;81(2):349-61. doi: 10.1111/bcp.12817. Epub 2016 Jan 17.

41.

[Diabetic kidney disease: current management and potential future options].

Krzesinski JM, Scheen AJ.

Rev Med Suisse. 2015 Aug 26;11(483):1534-8, 1540-2. French.

42.

Fluorodeoxyglucose F(18) Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection.

Lovinfosse P, Weekers L, Bonvoisin C, Bovy C, Grosch S, Krzesinski JM, Hustinx R, Jouret F.

Am J Transplant. 2016 Jan;16(1):310-6. doi: 10.1111/ajt.13429. Epub 2015 Aug 24.

43.

[THE TREATMENT OF HIGH BLOOD PRESSURE MUST BE TAILOR-MADE].

Krzesinski JM.

Rev Med Liege. 2015 May-Jun;70(5-6):286-91. French.

44.

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury.

Rowart P, Erpicum P, Detry O, Weekers L, Grégoire C, Lechanteur C, Briquet A, Beguin Y, Krzesinski JM, Jouret F.

J Immunol Res. 2015;2015:602597. doi: 10.1155/2015/602597. Epub 2015 Jul 15. Review.

45.

Onco-nephrology: Core Curriculum 2015.

Cohen EP, Krzesinski JM, Launay-Vacher V, Sprangers B.

Am J Kidney Dis. 2015 Nov;66(5):869-83. doi: 10.1053/j.ajkd.2015.04.042. Epub 2015 Jun 6. Review. No abstract available.

46.

[Depression as a common complication of systemic lupus erythematosus].

Lemaire B, Geron D, Malaise O, Krzesinski JM, Ansseau M, Scantamburlo G.

Rev Med Liege. 2015 Apr;70(4):215-8. Review. French.

47.

[Management of hypophosphatemia: a case report].

Huart J, Dubois B, Krzesinski JM, Jouret F.

Rev Med Liege. 2015 Apr;70(4):163-8. French.

48.

Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification.

Lagny MG, Jouret F, Koch JN, Blaffart F, Donneau AF, Albert A, Roediger L, Krzesinski JM, Defraigne JO.

BMC Nephrol. 2015 May 30;16:76. doi: 10.1186/s12882-015-0066-9.

49.

Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy.

Delanaye P, Cavalier E, Fafin C, Dubois BE, Krzesinski JM, Moranne O.

J Nephrol. 2016 Feb;29(1):99-103. doi: 10.1007/s40620-015-0196-y. Epub 2015 Apr 10.

PMID:
25857297
50.

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis.

Hanssen O, Castermans E, Bovy C, Weekers L, Erpicum P, Dubois B, Bours V, Krzesinski JM, Jouret F.

Clin Kidney J. 2014 Jun;7(3):282-5. doi: 10.1093/ckj/sfu019. Epub 2014 Mar 16.

Supplemental Content

Loading ...
Support Center